Legal Opinion

McFadden v. United States

Supreme Court of the United States

Decided June 18, 2015No. 14-378PublishedCited by 180 opinions

1Opinion of the CourtJustice Thomas

The Controlled Substance Analogue Enforcement Act of 1986 (Analogue Act) identifies a category of substances substantially similar to those listed on the federal controlled substance schedules, 21 U.S.C. § 802 (32)(A), and then instructs courts to treat those analogues, if intended for human consumption, as controlled substances listed on schedule I for purposes of federal law, § 813. The Controlled Substances Act (CSA) in turn makes it unlawful knowingly to manufacture, distribute, or possess with intent to distribute controlled substances. § 841(a)(1). The question presented in this case…

Also in this document: Concurring in the judgment.

2Cases cited19 opinions

  1. Neder v. United StatesSupreme Court of the United States · 1999
  2. Staples v. United StatesSupreme Court of the United States · 1994
  3. United States v. Detroit Timber & Lumber Co.Supreme Court of the United States · 1906
  4. Liparota v. United StatesSupreme Court of the United States · 1985
  5. Bryan v. United StatesSupreme Court of the United States · 1998

14 more not listed; retrieve them via the Exa API.

3Cited by180 opinions

  1. Joan Kedra v. Richard SchroeterCourt of Appeals for the Third Circuit · 2017
  2. United States v. Matthew JonesCourt of Appeals for the Seventh Circuit · 2020
  3. State v. Jones (Slip Opinion)Ohio Supreme Court · 2020
  4. State v. JordanOhio Supreme Court · 2023
  5. United States v. CoombsCourt of Appeals for the First Circuit · 2017

175 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API